Manas AI

Manas AI

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.manasai.co/

Last Round

Seed

Sep 24, 2025

Total Funding Raised

$50.6M

Momentum Score

50 /100

Company Overview

Manas AI is a biopharmaceutical company that develops a full-stack, artificial intelligence-driven drug discovery platform designed to reduce drug development timelines for the treatment of cancer and rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Subscription SaaS

AI Layer

Foundation

Keywords

AI drug discoverytechbiogenerative chemistryfull-stack biopharmabiology foundation modelneuro-symbolic AIAI biopharmain silico drug discoverydrug discovery platformtherapeutic developmentcancer drug discoveryoncology therapeuticsrare disease therapeuticsautoimmune disease therapeuticstarget identificationnovel molecule generation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Manas AI Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Manas AI Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 24, 2025
SeedJan 27, 2025

Key People

Founding team and executive leadership

Erez Kalir

Board Member, Advisor, Acting COO

Executive Team

Manas AI Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    Grew 44% QoQ, from 18 to 26 employees.

  • Apr 27, 2026

    Grew 59% QoQ from 17 to 27 employees.

Manas AI Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Manas AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Manas AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range26
Year Founded2025
Last FundingSep 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.